Omicron SARS-CoV-2 variant: Unique features and their impact on pre-existing antibodiesSaathvik R. Kannan, Kamal Singh, Austin N. Spratt et al.|Journal of Autoimmunity|2021Cited by 234
The Journey of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) from Lab to ClinicVigneshwaran Namasivayam, Siddappa N. Byrareddy|Journal of Medicinal Chemistry|2018Cited by 181
Placental Hofbauer cells assemble and sequester HIV‐1 in tetraspanin‐positive compartments that are accessible to broadly neutralizing antibodiesErica L. Johnson, Rana Chakraborty, Hin Chu et al.|Journal of the International AIDS Society|2015Cited by 28
Potential therapeutic targets for Mpox: the evidence to dateSiddappa N. Byrareddy, Kamal Singh, Kalicharan Sharma et al.|Expert Opinion on Therapeutic Targets|2023Cited by 20
Complex Mutation Pattern of Omicron BA.2: Evading Antibodies without Losing Receptor InteractionsSaathvik R. Kannan, Austin N. Spratt, Kalicharan Sharma et al.|International Journal of Molecular Sciences|2022Cited by 19